LQDA Q1 2024 Earnings — Liquidia Corporation Revenue & Financial Results | Market Cap Arena

LQDALiquidia Corporation

$3B

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M-33.9% YoY

Gross Profit

$1M40.9% margin

Operating Income

-$29M-969.1% margin

Net Income

-$41M-1377.1% margin

EPS (Diluted)

$-0.54

QoQ Revenue Growth

-34.4%

Cash Flow

Operating Cash Flow

-$25M

Free Cash Flow

-$25M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$197M

Total Liabilities

$111M

Stockholders' Equity

$86M

Cash & Equivalents

$158M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$4M	-33.9%
Gross Profit	$1M	$4M	-68.3%
Operating Income	-$29M	-$9M	-212.0%
Net Income	-$41M	-$12M	-248.5%